logo

For the Inventor, By the Inventor

Omiya, Japan

Hiroshi Wada

This inventor holds 5 USPTO granted patents. Top assignee: Tanabe Seiyaku Company, Limited. Active years: 1985-1989.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hiroshi Wada. Retrieved from https://idiyas.com/inventor/hiroshi-wada-lhdw7l4a

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 5

% Patents Active = 100.0

Average Co-Inventor Count = 4.3

ph-index = 3

Forward Citations = 45(Granted Patents)


Location History:

  • Omiya, JP (1985 - 1988)
  • Nishinomiya, JP (1989)

Company Filing History:

goldMedal5 out of 324 
 
Tanabe Seiyaku Company, Limited
 patents

Years Active: 1985-1989

Loading Chart...
5 patents (USPTO):Explore Patents
1. 4886817 - Imidazolidinones as brain activators (1989-12-12),
2. 4777178 - Thiazolidine derivatives (1988-10-11),
3. 4689327 - N-substituted-2-[2-[2-(4-p (1987-08-25),
4. 4565877 - Naphthalene derivatives and method for preparation thereof (1986-01-21),
5. 4529602 - Method for treatment or prophylaxis of gastro-intestinal disease (1985-07-16),

Title: Innovator Hiroshi Wada: A Pioneer in Medicinal Chemistry

Introduction: Hiroshi Wada, an accomplished inventor from Omiya, Japan, has made significant contributions to the field of medicinal chemistry. With a total of five patents to his name, Wada continually explores novel compounds that hold promise for therapeutic applications, impacting both the pharmaceutical industry and patient care.

Latest Patents: Among his latest innovations, Wada has developed a groundbreaking compound known as imidazolidinones, which function as brain activators. This invention specifically relates to imidazolidinone compounds with a unique formula that enhances cognitive functions. In addition, he has introduced thiazolidine derivatives, offering a novel approach as a cardiotonic agent. These thiazolidine derivatives boast a complex structure, with various functional groups designed to optimize their pharmacological effects. Both patents not only contribute to scientific advancements but also pave the way for new therapeutic strategies.

Career Highlights: Wada is affiliated with Tanabe Seiyaku Company, Limited, where he works diligently to develop innovative medicinal solutions. His efforts have placed him at the forefront of pharmaceutical research, allowing him to explore potential treatments that could greatly benefit patients dealing with various health challenges.

Collaborations: During his career, Wada has collaborated with notable colleagues in the field, including Hajime Tamaki and Hideo Nakai. Together, they have worked on advancing research and development projects aimed at enhancing the efficacy of therapeutic agents and addressing unmet medical needs.

Conclusion: Hiroshi Wada's ingenuity and dedication to innovation have established him as a key player in the realm of medicinal chemistry. With his latest patents contributing to brain activation and cardiotonic applications, Wada continues to push the boundaries of what is possible in medicine. His work not only exemplifies his commitment to improving health outcomes but also inspires future generations of inventors and researchers.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…